Yahoo Poland Wyszukiwanie w Internecie

Search results

  1. 3 dni temu · Hepatitis E is a viral infection that causes inflammation in your liver. Symptoms include fever, vomiting, abdominal pain, jaundice, dark pee, pale poop and itching. In most people, it gets better without treatment in a few weeks. But if you have hepatitis E while you’re pregnant, you’re at high risk for liver failure, miscarriage and ...

  2. 9 sie 2023 · INTRODUCTION. Hepatitis E virus (HEV) is one of the most common causes, yet least diagnosed etiologies, of acute viral hepatitis [1]. HEV infection has a global distribution, with distinct differences in transmission and disease outcomes in resource-rich versus resource-limited areas.

  3. 13 mar 2024 · Treatment for acute HEV infection is supportive in the majority of cases. Severe infection may require treatment with antiviral therapy to prevent progression to acute liver failure. Treatment options for chronic HEV infection include reduction of immunosuppression if appropriate to do so, ribavirin, and peginterferon alfa.

  4. 30 kwi 2018 · Infection with hepatitis E virus (HEV) is a significant cause of morbidity and mortality, representing an important global health problem. Our understanding of HEV has changed completely over the past decade. Previously, HEV was thought to be limited to certain developing countries.

  5. 26 cze 2023 · Introduction. Hepatitis E virus (HEV) is the most common cause of acute viral hepatitis in the world. Due to nonspecific symptoms and a self-limited disease course, it is also not frequently diagnosed. HEV is classified in the genus Orthohepevirus of the Hepeviridae family. It is an icosahedral, nonenveloped virus.

  6. 20 gru 2020 · Hepatitis E virus infection can cause chronic hepatitis in immunocompromised patients with significant chance of progressive fibrosis and possibly cirrhosis. The aim of this systematic review was to summarize the efficacy and safety of the various treatment options for chronic hepatitis E.

  7. 17 lip 2020 · Ribavirin therapy for a period of 3 months is the drug of choice for severe acute hepatitis, acute-on chronic liver failure, and chronic infections from hepatitis E virus in immunocompromised patients who are unresponsive to decreased immunosuppression.